Sigyn Therapeutics, Inc. (SIGY)
OTCMKTS: SIGY · Delayed Price · USD
4.750
-0.250 (-5.00%)
Jun 13, 2024, 3:31 PM EDT - Market closed
Sigyn Therapeutics Market Cap
Sigyn Therapeutics has a market cap or net worth of $6.00 million as of July 2, 2024. Its market cap has decreased by -96.67% in one year.
Market Cap
6.00M
Enterprise Value
8.62M
1-Year Change
-96.67%
Ranking
n/a
Category
Stock Price
$4.75
Market Cap Chart
Since July 3, 2019, Sigyn Therapeutics's market cap has decreased from $32.51M to $6.00M, a decrease of -81.54%. That is a compound annual growth rate of -28.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2024 | 6.46M | 9.31% |
| Dec 29, 2023 | 5.91M | -97.68% |
| Dec 30, 2022 | 254.30M | -65.91% |
| Dec 31, 2021 | 745.92M | -58.69% |
| Dec 31, 2020 | 1.81B | 12,998.73% |
| Dec 31, 2019 | 13.78M | -57.60% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 860.48B |
| Novo Nordisk | 629.27B |
| UnitedHealth Group | 468.72B |
| Johnson & Johnson | 351.76B |
| Merck & Co. | 313.56B |
| AbbVie | 302.88B |
| AstraZeneca | 241.81B |
| Thermo Fisher | 211.09B |